Get the Stockscreener App
2.92
7.15%
-0.225
Cdt Equity Inc stock is traded at $2.92, with a volume of 28,093.
It is down -7.15% in the last 24 hours and down -16.57% over the past month.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
See More
Previous Close:
$3.145
Open:
$2.97
24h Volume:
28,093
Relative Volume:
0.04
Market Cap:
$1.84M
Revenue:
-
Net Income/Loss:
$-39.62M
P/E Ratio:
-0.00177
EPS:
-1654.3275
Net Cash Flow:
$-17.96M
1W Performance:
-14.62%
1M Performance:
-16.57%
6M Performance:
-98.92%
1Y Performance:
-99.91%
1-Day Range:
$2.80
$3.08
1-Week Range:
$2.80
$3.4499
52-Week Range:
$2.53
$3,460.60
Cdt Equity Inc Stock (CDT) Company Profile
Name
Cdt Equity Inc
Sector
Industry
Phone
(646) 491 9132
Address
4851 TAMIAMI TRAIL NORTH, NAPLES
Compare CDT vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDT
Cdt Equity Inc
|
2.92 | 1.85M | 0 | -39.62M | -17.96M | -1,654.33 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Cdt Equity Inc Stock (CDT) Latest News
CDT Equity Inc. Q2 2026: Net loss $(4.64M), EPS $(8.71) — 10-Q Summary - TradingView
CDT Equity Inc. (CDT) flags going concern risk despite Sarborg investment gain - Stock Titan
CDT Equity Inc. SEC Filing (Aug 11, 2026) - Stock Titan
CDT Equity Expands Convertible Note and Equity Financing - The Globe and Mail
CDT Equity Inc. Revenue Breakdown – BOATS:CDTTW - TradingView
CDT Equity to Boost Stake in Sarborg - marketscreener.com
Press Release: CDT Increases Stake in Sarborg Following Its Quantum Computing and Intellectual Property Expansion - 富途牛牛
CDT Equity boosts stake in Sarborg amid its qua... - Pluang
CDT Equity Inc. agreed to acquire 22.70% stake in Sarborg Limited. - marketscreener.com
CDT Equity Expands Stake in Sarborg Via Warrants - The Globe and Mail
CDT Equity Inc. Revenue Breakdown – NASDAQ:CDT - TradingView
Form PRE 14A CDT Equity Inc For: 31 July By Investing.com - Investing.com Nigeria
CDT Equity to Acquire 4.76% of Sarborg; Issues Pre-Funded Warrants for 12.13M Shares - TradingView
CDT Equityto Buy 4.76% of SarborgSEC Fi - Moomoo
CDT Equity (NASDAQ: CDT) trades Sarborg stake for pre-funded warrants - Stock Titan
CDT Equity (NASDAQ: CDT) pays consultant with 32,110 shares - Stock Titan
CDT Equity Inc. Revenue Breakdown – NASDAQ:CDTTW - TradingView
CDT|Conduit Pharmaceuticals Inc|Price:3.060|Chg%:-0.210 - TradingKey
Conduit Pharmaceuticals Inc (CDT) Income Statement - TradingKey
Ulrik K Olsen Net Worth (2026) - GuruFocus
CDT Equity Inc. Revenue Breakdown – FWB:ZK70 - TradingView
CDT Equity Company Profile & Introduction - Moomoo
CDT Equity Inc. (CDT) Stock Price, News, Quote & History - Yahoo! Finance Canada
CDT Equity notes Sarborg patent filing on sugarcane interventions - Investing.com UK
CDT Equity notes Sarborg patent filing on sugarcane interventions By Investing.com - Investing.com Nigeria
CDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to Sugarcane - The Manila Times
CDT Equity Announces Reverse Stock Split on Nasdaq - The Globe and Mail
CDT Equity announces 1-for-10 reverse stock split - MSN
CDT Stock Quote Price and Forecast - CNN
CDT Equity Inc. Announces Reverse Stock Split - Moomoo
CDT Equity announces 1-for-10 reverse stock split to maintain Nasdaq listing compliance - Bitget
CDT Equity: Reverse Split To Ensure Continued Compliance With the Nasdaq Bid-Price Rule >CDT - Moomoo
CDT Equity approves 1-for-10 reverse stock split effective Friday - Investing.com Australia
CDT Equity Inc. (CDT) Faces Sharp Decline, Tests Key Support at $0.28Catalyst Driven Stocks - dars.gov.et
CDT Equity Inc. Announces 1-for-10 Reverse Stock Split to Maintain Nasdaq Listing - Minichart
CDT Equity Inc. (Nasdaq: CDT) approves 1-for-10 reverse stock split - Stock Titan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
CDT Equity Inc. 1Q 2026: Net loss $(4.06)M, EPS $(5.56) — 10-Q Summary - TradingView
CDT Equity (Nasdaq: CDT) flags going concern risk after Q1 2026 loss - Stock Titan
CDT Equity Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
CDT|Conduit Pharmaceuticals Inc|Price:2.820|Chg%:-0.240 - TradingKey
CDT Equity Inc. (CDT) Slips 2.4% as Stock Consolidates Near Key SupportDebt Free Companies - po-news-eg.net
Enterprise value to revenue forward of CDT Equity Inc. – BOATS:CDTTW - TradingView
Price to book forward of CDT Equity Inc. – BOATS:CDTTW - TradingView
CDT Equity Amends Convertible Note and Repayment Terms - TipRanks
CDT Equity Amends $1.97M Secured Convertible Note With J.J. Astor, Sets 24 Weekly Payments - TradingView
CDT Equity (NASDAQ: CDT) resets $1.97M convertible loan repayment schedule - Stock Titan
CDTTW Holds Steady at $0.01 – Flat Trading Reflects Stalemate for CDT Equity Inc. WarrantsStrong Buy Stocks - dars.gov.et
CDT Environmental Technology Investment Holdings Limited to Hold Extraordinary General Meeting on July 28, 2026 - Yahoo Finance
CDTTW Drops 15.5% to $0.01: Key Levels in Focus for CDT Equity WarrantsPositive Gamma - dars.gov.et
Price to earnings forward of CDT Equity Inc. – NASDAQ:CDT - TradingView
Cdt Equity Inc Stock (CDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):